Accreditation Statements

Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Nurses
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The Institute for Johns Hopkins Nursing and the American Nurses Credentialing Center do not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.

Credit Designations

Physicians
eNewsletter: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Podcast: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
eNewsletter: This 1 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Newsletter carries a maximum of 1 contact hour, or a total of 8 contact hours for the 8 newsletters in this program.

Podcast: These paired 0.5 contact hour Educational Activities are provided by the Institute for Johns Hopkins Nursing. Each podcast carries a maximum of 0.5 contact hour, or a total of 3 contact hours for the 6 podcasts in this program.

To obtain contact hours, you must complete this Education Activity and post-test before September 16, 2018.

Course Format

The eDiabetes Review series will consist of a monthly review of journal literature on key, pertinent topics, emailed as either a newsletter or podcast, to clinicians caring for patients with diabetes. The timely commentary on current research, best practices and clinical management issues is provided by an expert panel of diabetes specialists. The activities are delivered as 8 bi-monthly newsletters and 6 alternating podcasts. Participants will have up to 2 years to complete the 8 newsletters and 6 podcasts in order to earn CME credit.
Date of release: September 2, 2015
Activities expire two years from the date of the publication.
Estimated time to complete each activity: 60 minutes per newsletter, 30 minutes per podcast

Statement of Responsibility

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Intended Audience

The target audience (clinicians) for this initiative includes endocrinologists, primary care clinicians, nurse practitioners, physician assistants, Certified Diabetes Educators, and other health care practitioners whose work/practice includes treating patients with T2DM.

Learning Objectives

• Describe SGLT2 inhibitors, including benefits, side effects, and appropriate patient criteria.
• Explain the benefits of fixed-dose OADs and identify fixed-dose OADs that are newly emerging or in development.
• Distinguish how new GLP-1/insulin and basal/insulin combinations, differ from their predecessors.
• Identify conflicting evidence in macronutrient management and apply the information to individual patient situations.
• Describe the clinician-patient discrepancies in current attempts at patient-centered care.
• Discuss practice changes required to investigate patient-centered care.

Launch Date:
September 2, 2015; activities expire two years from the date of the publication.

Planners Disclosures

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:

Kathleen Dungan, MD, MPH discloses that she is a principal investigator for AstraZeneca, GlaxoSmithKline, Sanofi-Aventis, Grifols, Merck & Co., Inc., and Regeneron Pharmaceuticals, Inc. She has served as a consultant for GlaxoSmithKline and Eli Lilly and Company, and has received honorarium from UpToDate®.

No other planners have indicated that they have any financial interest or relationships with a commercial entity.

Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Statement of Need

• Patients are not receiving the therapeutic benefits of SGLT2 inhibitors because of inadequate clinician understanding of these agents.
• New fixed-dose combination OADs present benefits clinicians may not be providing for their patients.
• Fixed-dose insulin/GLP-1 RA combinations may be underused because of lack of clinician understanding.
• Patients do not receive appropriate dietary recommendations because of conflicting data.
• Actual delivery of “patient-centered care” does not match clinicians’ perceptions.

Disclaimer Statement

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

Successful Completion

To take the post-test for eDiabetes Review you will need to visit the Johns Hopkins University School of Medicine's CME website or the Institute for Johns Hopkins Nursing website. If you have already registered for other Hopkins CE programs at these sites, simply enter the requested information when prompted. Otherwise, complete the registration form to begin the testing process. A passing grade of 70% or higher on the post-test/evaluation is required to receive CE credit.

There are no fees or prerequisites for this activity.

This activity is supported by educational grants from AstraZeneca and Merck & Co., Inc.

Confidentiality Disclaimer For CME Activity Participants

I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the Privacy Regulations). Protected health information is information about a person's health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.

"The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only."

For CME Questions, please contact the CME Office
(410) 955-2959 or e-mail cmenet@jhmi.edu.
For CME Certificates, please call (410) 502-9634.

Johns Hopkins University School of Medicine Office of Continuing Medical Education
Turner 20/720 Rutland Avenue
Baltimore, Maryland 21205-2195

Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)

Hardware & Software Requirements

• A computer with an internet connection
• An HTML5 compliant web browser or Internet Explorer 8 (and higher)

To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit www.hopkinscme.edu.

Copyright © JHUSOM and eDiabetes Review | Presented by JHUSOM, IJHN in collaboration with DKBmed.

Accreditation Statements

Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Nurses
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The Institute for Johns Hopkins Nursing and the American Nurses Credentialing Center do not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.

Credit Designations

Physicians
eNewsletter: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Podcast: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
eNewsletter: This 1 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Newsletter carries a maximum of 1 contact hour, or a total of 6 contact hours for the six newsletters in this program.

Podcast: These paired 0.5 contact hour Educational Activities are provided by the Institute for Johns Hopkins Nursing. Each podcast carries a maximum of 0.5 contact hour, or a total of 3 contact hours for the 6 podcasts in this program.

To obtain contact hours, you must complete this Education Activity and post-test before May 21, 2017.

Course Format

The eDiabetes Review series will consist of a monthly review of journal literature on key, pertinent topics, emailed as either a newsletter or podcast, to clinicians caring for patients with diabetes. The timely commentary on current research, best practices and clinical management issues is provided by an expert panel of diabetes specialists. The activities are delivered as 6 bi-monthly newsletters and 6 alternating podcasts. Participants will have up to 2 years to complete the 6 newsletters and 6 podcasts in order to earn CME credit.
Date of release: April 3, 2014
Expiration date: May 20, 2017
Estimated time to complete each activity: 60 minutes per newsletter, 30 minutes per podcast

Internet CME Policy

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. The Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals, and the public.

Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in an Internet-based CME program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.

Statement of Responsibility

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Intended Audience

The target audience (clinicians) for this initiative includes endocrinologists, primary care clinicians, nurse practitioners, physician assistants, Certified Diabetes Educators, and other health care practitioners whose work/practice includes treating patients with T2DM.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

• Explain the need to intensify glycemic control and the most effective treatment modalities
• Evaluate patient selection criteria for the use of GLP-1 receptor antagonist agents
• Assess potential strategies and devices for improving self-monitoring
• Describe the evidence-based benefits of CVD risk factor control in patients with T2DM
• Describe the appropriateness of newly approved therapeutic options and ongoing research into new treatment modalities that may improve outcomes
• Assess current options for weight control counseling and pharmacologic treatment

Launch Date

September 2, 2015; activities expire two years from the date of the publication.

Planners Disclosures

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:

Kathleen Dungan, MD, MPH discloses that she is a principal investigator for AstraZeneca, GlaxoSmithKline, Sanofi-Aventis, Grifols, Merck & Co., Inc., and Regeneron Pharmaceuticals, Inc. She has served as a consultant for GlaxoSmithKline and Eli Lilly and Company, and has received honorarium from UpToDate®.

No other planners have indicated that they have any financial interest or relationships with a commercial entity.

Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Statement of Need

• Clinicians do not appropriately intensify therapy as necessary to maintain glycemic control.
• Conflicting data about the safety of incretin agents may unduly deprive patients of treatment benefits.
• Clinicians are not aware of and/or are not implementing strategies to maximize the value of self-monitoring of blood glucose (SMBG) readings to improve patient outcomes.
• Clinicians do not adequately understand or treat to control CVD risk factors in their patients with T2DM.
• Clinicians do not have a sufficiently current knowledge base to effectively consult patients about potential T2DM therapeutic advances.
• Clinicians do not adequately counsel and treat their overweight/obese patients with T2DM.

Disclaimer Statement

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

Successful Completion

To take the post-test for eDiabetes Review you will need to visit the Johns Hopkins University School of Medicine's CME website or the Institute for Johns Hopkins Nursing website. If you have already registered for other Hopkins CE programs at these sites, simply enter the requested information when prompted. Otherwise, complete the registration form to begin the testing process. A passing grade of 70% or higher on the post-test/evaluation is required to receive CE credit.

There are no fees or prerequisites for this activity.

This activity is supported by educational grants from AstraZeneca, Eli Lilly and Company and Novo Nordisk, Inc.

Confidentiality Disclaimer for CME Activity Participants

I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the Privacy Regulations). Protected health information is information about a person's health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos on any social medial site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.

"The Office of Continuing Medical Education at The Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only."

For CME questions, please contact the CME Office (410) 955-2959 or e-mail cmenet@jhmi.edu. For certificates, please call (410) 502-9634.

Johns Hopkins University School of Medicine Office of Continuing Medical Education
Turner 20/720
Rutland Avenue
Baltimore, Maryland 21205-2195

Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)

Hardware & Software Requirements

• A computer with an internet connection
• An HTML compliant web browser or Internet Explorer 8 (and higher)

Copyright © JHUSOM and eDiabetes Review | Presented by JHUSOM, IJHN in collaboration with DKBmed.